What science understands about why Type 1 diabetes happens: autoimmunity, genetics, environmental and viral triggers, and the gaps researchers are still working to close.
A recent study published in PLOS Medicine investigates the effectiveness and safety of statin therapy for primary cardiovascular disease prevention in older adults with type 2 diabetes.
A recent systematic review sheds light on the role of islet autoantibodies in predicting type 1 diabetes development, with a focus on African populations.
A rare autoimmune condition can cause cognitive and neurological decline in people with type 1 diabetes. A recent case study shows that a specific treatment may help manage this complication.
New research explores the fluctuations of lipoprotein(a) levels in young people with type 1 diabetes, and what this means for their cardiovascular health.
A recent network meta-analysis compared ultra-short-acting insulin analogues to regular human insulin in adults with type 1 diabetes. Here's what we learned.
Research sheds light on how Coxsackievirus B interacts with the immune system, potentially contributing to the development of type 1 diabetes.
Researchers identify key proteins associated with reduced cardiovascular risk in people with long-standing Type 1 diabetes.
A breakthrough therapy offers a chance to delay the onset of type 1 diabetes in children and adolescents. But what does this mean, exactly?
A recent study published in PloS one found that iscalimab, a therapeutic anti-CD40 monoclonal antibody, showed limited efficacy in inhibiting activated CD4 T cell autoimmunity in vitro.
Researchers have made a significant discovery about the genetic drivers behind two common conditions that often occur together in heart failure patients.
A study shows that identifying at-risk children and following them closely can lead to milder symptoms and better treatment outcomes for type 1 diabetes.
Research in the Scottish Type 1 Bioresource Cohort finds associations between C-peptide levels and long-term clinical outcomes.
A recent study sheds light on a possible cause of diabetic peripheral neuropathy, pointing to a key role for serine metabolism.
Research reveals the complex genetic and metabolic factors that contribute to an increased risk of diabetes in individuals with Down syndrome.
Researchers investigate the role of sphingosine-1-phosphate and its receptors in type 1 diabetes, uncovering some surprising differences between patients and healthy individuals.
Researchers are exploring a new class of biotherapeutics called single-chain variable fragments (scFv) that could revolutionize the treatment of diabetes.
Researchers have made significant discoveries about the genetic factors that influence blood sugar control and type 1 diabetes risk in diverse populations.
Researchers are exploring the use of chimeric antigen receptor (CAR) technology to target and eliminate specific cells involved in autoimmune diseases, including Type 1 diabetes.
Researchers have shed light on the distribution of HLA alleles in the Russian population, providing valuable insights into the genetic risk factors for type 1 diabetes.
New research shows that people with type 1 diabetes are at increased risk of mortality if they have multiple chronic conditions. The longer someone has had type 1 diabetes, the more likely they are to develop multimorbidity.
Researchers have used advanced simulations to explore how a specific mutation in the insulin peptide affects its interaction with immune cells, providing new clues about the development of Type 1 diabetes.
Scientists investigate the potential of a single intravenous dose of engineered bacteria to delay or prevent Type 1 diabetes in mice.
Research suggests that the balance of gut bacteria may play a role in the development of type 1 diabetes, but more study is needed to understand this complex relationship.
New research reveals that ISG15 plays a crucial role in the resistance of alpha cells to viral infections, which may help explain why these cells survive in people with Type 1 diabetes.
A recent case report highlights the potential link between influenza A infection and the development of type 1 diabetes, particularly in individuals with underlying autoimmune conditions.
A recent review sheds light on the intricate mechanisms behind type 1 diabetes, highlighting the convergence of genetic predisposition and environmental triggers.
A recent study published in Diabetologia examined the relationship between SARS-CoV-2 infections and type 1 diabetes incidence among individuals under 30 years old in Sweden.